PS01.04 International Tailored Chemotherapy Adjuvant Trial : ITACA Trial. Final Results
Abstract
Adjuvant platinum-based chemotherapy in early stage non-small cell lung cancer confers a modest 5% overall survival benefit. Different strategies have been investigated to improve these results. mRNA expression of some genes was correlated with the sensitivity or resistance to specific anticancer agents. We aimed to evaluate the predictive utility of the mRNA expression levels of molecular markers ERCC1 and...
Paper Details
Title
PS01.04 International Tailored Chemotherapy Adjuvant Trial : ITACA Trial. Final Results
Published Date
Mar 1, 2021
Journal
Volume
16
Issue
3
Pages
S58 - S59
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History